Dare Bioscience, Inc.
DAREDare Bioscience is a biopharmaceutical company dedicated to identifying, developing, and bringing to market innovative products for women's health.
Table of contents
Earnings
Next report
Aug 13, 2026 (In 2 weeks)Competitors
By market cap
By revenue growth
Profile
Dare Bioscience is a biopharmaceutical company dedicated to identifying, developing, and bringing to market innovative products for women's health. The company leverages a differentiated business model that includes traditional FDA regulatory pathways, Section 503B compounding for proprietary formulations, and non-prescription consumer health products. Their core value proposition centers on addressing unmet needs in contraception, sexual health, and vaginal health through a diverse portfolio of clinical-stage and commercial assets.
Dare positions itself as a first-in-category innovator in underserved women's health indications, utilizing a capital-efficient model that avoids building internal large-scale manufacturing or sales forces.
Questions, answered.
- What is Dare Bioscience, Inc.'s market cap?
- Dare Bioscience, Inc. (DARE) has a market capitalization of $17.8M and trades on NASDAQ.
- Who are Dare Bioscience, Inc.'s competitors?
- Dare Bioscience, Inc.'s key competitors include Merck, Scienture Holdings, Inc. Common Stock, Nutriband Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does Dare Bioscience, Inc. partner with?
- Dare Bioscience, Inc.'s notable partners include Organon, Bayer, XOMA, and others.
- What subsidiaries does Dare Bioscience, Inc. have?
- Dare Bioscience, Inc.'s subsidiaries include Dare MB Inc..
- Where is Dare Bioscience, Inc. headquartered?
- Dare Bioscience, Inc. is headquartered in United States of America and employs approximately 26 people. It has been publicly traded since 2014.